Vol 44, No 2 (2013)
Prace poglądowe / Reviews
Published online: 2013-04-01

open access

Page views 188
Article views/downloads 1666
Get Citation

Connect on Social Media

Connect on Social Media

Thrombocytopenia – indications for thrombopoietic cytokines administration

Janusz Kłoczko, Anna Szumowska1, Marzenna Galar1
DOI: 10.1016/j.achaem.2013.02.017
Acta Haematol Pol 2013;44(2):130-134.

Abstract

The most common cause of isolated thrombocytopenia is primary immune thrombocytopenia (ITP). For patients failing initial corticosteroid-based treatment and with refractory ITP post-splenectomy, thrombopoietin receptor agonists are indicated. Two of this thrombopoiesis-stimulating agents have been approved for use in ITP – eltrombopag, formulated for oral administration, once a day and romiplostim, which is administered weekly as a subcutaneous injection.

Article available in PDF format

View PDF (Polish) Download PDF file